Pro Medicus Financials

PME Stock   268.64  0.25  0.09%   
We recommend to use Pro Medicus fundamental analysis to see if markets are presently undervaluing or overvaluing the firm. Put it differently, this technique allows you to confirm available drivers of Pro Medicus as well as the relationship between them. We were able to analyze and collect data for twenty-eight available financial ratios for Pro Medicus, which can be compared to its competitors. The stock experiences a normal downward trend and little activity. Check odds of Pro Medicus to be traded at 265.95 in 90 days. Key indicators impacting Pro Medicus' financial strength include:
Operating Margin
0.7307
PE Ratio
345.5
Profit Margin
0.5127
Payout Ratio
1.1604
EPS Estimate Current Year
1.0732
  
Please note, the imprecision that can be found in Pro Medicus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pro Medicus. Check Pro Medicus' Beneish M Score to see the likelihood of Pro Medicus' management manipulating its earnings.

Pro Medicus Stock Summary

Pro Medicus competes with IShares Global, Adriatic Metals, Australian Agricultural, and VanEck FTSE. Pro Medicus is entity of Australia. It is traded as Stock on AU exchange.
Foreign Associate
  USA
Specialization
Health Care, Health Care Equipment & Services
InstrumentAustralia Stock View All
ExchangeAustralian Securities Exchange
ISINAU000000PME8
Business Address450 Swan Street,
SectorHealth Care Technology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.promed.com.au
Phone61 3 9429 8800
You should never invest in Pro Medicus without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Pro Stock, because this is throwing your money away. Analyzing the key information contained in Pro Medicus' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Pro Medicus Key Financial Ratios

Pro Medicus' financial ratios allow both analysts and investors to convert raw data from Pro Medicus' financial statements into concise, actionable information that can be used to evaluate the performance of Pro Medicus over time and compare it to other companies across industries.

Pro Medicus Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets125.6M157.1M202.1M257.4M296.0M310.8M
Other Current Liab5.6M8.2M10.0M12.8M14.7M15.5M
Net Debt(39.4M)(61.4M)(89.4M)(58.0M)(52.2M)(49.6M)
Retained Earnings66.9M92.6M127.1M173.4M199.4M209.3M
Accounts Payable872K1.6M1.0M1.7M2.0M2.1M
Cash42.0M63.7M91.2M60.1M69.1M72.5M
Net Receivables24.4M27.4M40.7M49.2M56.6M59.4M
Inventory34K77K55K49K44.1K75.3K
Total Liab43.9M55.3M63.4M69.7M80.2M84.2M
Total Current Assets87.6M119.8M163.8M206.6M237.5M249.4M
Short Term Debt574K604K1.4M553K636.0K604.2K
Other Liab21.0M24.2M26.8M31.3M36.0M37.8M
Other Assets13.2M40.5M1.012.4M1.151.09
Other Current Assets1.3M1.8M1.6M1.9M1.7M950.4K
Intangible Assets20.0M22.3M21.3M20.1M23.1M24.2M
Net Tangible Assets41.3M61.7M79.4M117.4M135.0M141.8M
Long Term Debt Total1.8M2.0M1.7M1.2M1.4M1.0M
Net Invested Capital81.7M101.7M138.8M187.7M215.9M226.7M
Net Working Capital69.9M93.0M132.9M172.0M197.8M207.7M

Pro Medicus Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense5K538K649K386K347.4K687.2K
Operating Income42.4M62.4M83.9M112.2M129.0M135.5M
Ebit42.9M63.1M86.1M112.2M129.0M135.5M
Ebitda50.1M70.4M94.1M120.7M138.8M145.7M
Income Before Tax42.9M63.1M86.1M116.5M134.0M140.7M
Net Income30.9M44.4M60.6M82.8M95.2M100.0M
Income Tax Expense12.0M18.6M25.5M33.7M38.8M40.7M
Total Revenue67.9M93.5M124.9M161.5M185.7M195.0M
Cost Of Revenue21.2M23.2M32.5M39.2M45.1M47.3M
Gross Profit46.7M70.3M92.4M122.3M140.7M147.7M
Research Development6.8M6.4M6.5M7.1M8.2M8.6M
Tax Provision12.0M18.6M25.5M33.7M38.8M40.7M
Net Interest Income180K649K2.4M4.8M5.6M5.8M
Interest Income180K649K2.4M4.8M5.6M5.8M

Pro Medicus Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash(1.4M)21.6M27.6M(31.2M)(35.9M)(34.1M)
Free Cash Flow31.1M52.6M56.1M80.1M92.1M96.7M
Other Non Cash Items7.2M16.3M1.1M86.7M99.7M104.7M
Capital Expenditures7.7M9.0M6.4M6.7M7.7M8.1M
Net Income30.9M44.4M60.6M82.8M95.2M100.0M
End Period Cash Flow42.0M63.7M91.2M60.1M69.1M72.5M
Change To Inventory1K(43K)22K6K5.4K5.7K
Dividends Paid13.5M18.8M26.1M36.6M42.0M44.1M
Depreciation803K813K834K8.5M9.8M10.3M
Change To Netincome3.6M2.1M395K(240K)(276K)(262.2K)
Investments(19.7M)(8.5M)(7.6M)(73.3M)(65.9M)(62.7M)

Pro Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Pro Medicus's current stock value. Our valuation model uses many indicators to compare Pro Medicus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pro Medicus competition to find correlations between indicators driving Pro Medicus's intrinsic value. More Info.
Pro Medicus is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.60  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pro Medicus is roughly  1.65 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pro Medicus' earnings, one of the primary drivers of an investment's value.

Pro Medicus Systematic Risk

Pro Medicus' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pro Medicus volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Pro Medicus correlated with the market. If Beta is less than 0 Pro Medicus generally moves in the opposite direction as compared to the market. If Pro Medicus Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pro Medicus is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pro Medicus is generally in the same direction as the market. If Beta > 1 Pro Medicus moves generally in the same direction as, but more than the movement of the benchmark.

Pro Medicus Total Assets Over Time

Pro Medicus January 29, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Pro Medicus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pro Medicus. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pro Medicus based on widely used predictive technical indicators. In general, we focus on analyzing Pro Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pro Medicus's daily price indicators and compare them against related drivers.

Additional Tools for Pro Stock Analysis

When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.